1,25-Dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro
- 1 February 1993
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 35 (2), 177-182
- https://doi.org/10.1016/0165-2478(93)90088-j
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 1,25-dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferationImmunology Letters, 1992
- 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and productionBiochemical and Biophysical Research Communications, 1991
- Accessory Signals in T‐T Cell Interactions Between Antigen‐ and Alloantigen‐Specific, Human Memory T Cells Generated in VitroScandinavian Journal of Immunology, 1990
- 1,25-dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor bindingCellular Immunology, 1990
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989
- Differences between Primed Allogeneic T‐Cell Responses and the Primary Mixed Leucocyte ReactionScandinavian Journal of Immunology, 1988
- Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 productionCellular Immunology, 1986
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.JCI Insight, 1984
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983